Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioMedomics
AddedFeb 15, 2024
UpdatedJun 18, 2026
BioMedomics

BioMedomics

Pre-Seed

BioMedomics, a US-based company, manufactures bioscience products and medical devices, offers contract assay services, and conducts drug discovery research.

HQ
Durham, NC, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

BioMedomics, founded in Durham, North Carolina, is dedicated to revolutionizing healthcare through innovative diagnostic solutions. The company's core mission is to develop and market advanced bioscience products and medical devices that address critical global health needs. Their flagship product, Sickle SCAN, is the world's first point-of-care test for sickle cell disease (SCD), known for its ease of use, affordability, and accuracy. BioMedomics also offers a range of products including DNA research reagents, tissue array products, and antibodies, alongside contract assay services for various cell-based assays.

Notable figures associated with BioMedomics include key researchers and industry experts who have driven the company's innovations. The company has attracted significant investment from healthcare-focused venture capital firms, bolstering its research and development capabilities. BioMedomics' achievements include ISO 13485 certification and the successful commercialization of Sickle SCAN, which has had a substantial impact on SCD diagnosis worldwide. Their contributions have significantly advanced the field of medical diagnostics, improving patient outcomes and accessibility to critical healthcare services.

BioMedomics - Similar Companies

Sedia Biosciences logo

Sedia Biosciences

sediabio.com

BioFluidica logo

BioFluidica

biofluidica.com

Biomeme logo

Biomeme

bio-meme.com

Biomimedica logo

Biomimedica

biomimedica.com

Biomedix Vascular Solutions logo

Biomedix Vascular Solutions

biomedix.com

Autonomous Medical Devices logo

Autonomous Medical Devices

amdilabs.com

Diomics logo

Diomics

IncellDx logo

IncellDx

healthbioai.com

Banyan Biomarkers logo

Banyan Biomarkers

Gemelli Biotech logo

Gemelli Biotech

gemellibiotech.com

International Biomedical Devices logo

International Biomedical Devices

aperturectc.com

Biomirror Diagnostics logo

Biomirror Diagnostics

Intellimedix logo

Intellimedix

American Bio Medica logo

American Bio Medica

Biodesix logo

Biodesix

biodesix.com

BioMedomics - Quick Facts

Who are BioMedomics' competitors?

Companies similar to BioMedomics include Sedia Biosciences, BioFluidica, Biomeme and Biomimedica.

When was BioMedomics founded?

BioMedomics was founded in 2006.

Where is BioMedomics' headquarters located?

BioMedomics' headquarters is located in Durham, NC, US.

How much has BioMedomics raised to-date?

As of Jan 1, 2018, BioMedomics has raised a total of $1.2M (USD).

How many employees does BioMedomics have?

BioMedomics has 18 employees as of Feb 5, 2024.

BioMedomics - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostics
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified